Acadia Healthcare Company Inc. (NASDAQ:ACHC) experienced a significant after-hours plunge of 13.34% following the release of its fourth-quarter 2024 financial results and full-year 2025 outlook. The healthcare company, which provides behavioral healthcare services across the United States and Puerto Rico, reported mixed results that fell short of analyst expectations.
In the fourth quarter, Acadia Healthcare generated revenue of $774.238 million, missing the consensus estimate of $779 million. Additionally, the company's adjusted EBITDA of $153.1 million fell short of the expected $171.4 million. Despite these misses, the company reported net income of $33.529 million for the quarter.
Looking ahead, Acadia Healthcare provided guidance for the full year 2025 that may have disappointed investors. The company expects revenue in the range of $3.3 billion to $3.4 billion and adjusted EBITDA between $675 million and $725 million. Furthermore, Acadia Healthcare anticipates capital expenditures ranging from $525 million to $575 million as it continues to invest in expanding its psychiatric bed capacity to meet the growing demand for mental health services.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。